KIB OpenIR
Neo-clerodane and abietane diterpenoids with neurotrophic activities from the aerial parts of Salvia leucantha Cav.
Li, Lai-Wei; Qi, Yan-Yan; Liu, Shi-Xi; Wu, Xing-De; Zhao, Qin-Shi
2018
发表期刊FITOTERAPIA
ISSN0367-326X
卷号127页码:367-374
摘要Four new neoclerodane diterpenoids, leucansalvialins F-I (1 4), and one rare 18(4 3)-abeo-abietane diterpenoid, leucansalvialin J (5), were isolated from the aerial part of Salvia leucantha Cav., along with 14 known analogues. Leucansalvialin F (1) represents the first rearranged salvigenane type clerodane-17,12:18,6-diolide. Their structures were elucidated by 1D and 2D NMR spectroscopic data analysis, and the absolute configurations of 1, 2, 3, and 5 were determinded by X-ray diffraction crystal analysis and the ECD technique. All of the isolated components were evaluated for their neurotrophic activities on PC12 cells and all new compounds were evaluated for their cytotoxicity against five human cancer cell lines (HL-60, A-549, SMMC-7721, MCF-7, and SW480). Compounds 2 and 5 showed moderate neuroprotective effects in an in vitro assay.
收录类别SCI
语种英语
文献类型期刊论文
条目标识符http://ir.kib.ac.cn/handle/151853/64734
专题中国科学院昆明植物研究所
推荐引用方式
GB/T 7714
Li, Lai-Wei,Qi, Yan-Yan,Liu, Shi-Xi,et al. Neo-clerodane and abietane diterpenoids with neurotrophic activities from the aerial parts of Salvia leucantha Cav.[J]. FITOTERAPIA,2018,127:367-374.
APA Li, Lai-Wei,Qi, Yan-Yan,Liu, Shi-Xi,Wu, Xing-De,&Zhao, Qin-Shi.(2018).Neo-clerodane and abietane diterpenoids with neurotrophic activities from the aerial parts of Salvia leucantha Cav..FITOTERAPIA,127,367-374.
MLA Li, Lai-Wei,et al."Neo-clerodane and abietane diterpenoids with neurotrophic activities from the aerial parts of Salvia leucantha Cav.".FITOTERAPIA 127(2018):367-374.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Li, Lai-Wei]的文章
[Qi, Yan-Yan]的文章
[Liu, Shi-Xi]的文章
百度学术
百度学术中相似的文章
[Li, Lai-Wei]的文章
[Qi, Yan-Yan]的文章
[Liu, Shi-Xi]的文章
必应学术
必应学术中相似的文章
[Li, Lai-Wei]的文章
[Qi, Yan-Yan]的文章
[Liu, Shi-Xi]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。